Reduced tumor oxygenation by treatment with vinblastine

Cancer Research

Volumn 61, Issue 10, 2001, Pages 4266-4271

  Sersa, G ^a   Krzic, M ^b   Sentjurc, M ^b   Ivanusa, T ^c   Beravs, K ^b   Cemazar, M ^a   Auersperg, M ^a   Swartz, H M ^d  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VINBLASTINE;

ACIDIFICATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG EFFECT; HYPOXIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; POLYMERIZATION; PRIORITY JOURNAL; TARGET CELL; TISSUE OXYGENATION; TUMOR BLOOD FLOW; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; FIBROSARCOMA; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED A; NEOPLASMS, EXPERIMENTAL; OXYGEN; VINBLASTINE;

EID: 0035872435     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
2. Modification of tumor blood flow: Current status and future directions
3. Acid pH in tumors and its potential for therapeutic exploitation
4. Vascular occlusion and tumour cell death
5. Is angiogenesis inhibition the Holy Grail of cancer therapy?
6. Tumor vasculature as a target for cancer therapy
7. Exploitation of bioreductive agents with vasoactive drugs
8. Tumour blood flow changes induced by application of electric pulses
9. The effect of therapy on tumor vascular function
10. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine
11. Drugs used in cancer chemotherapy
12. Intravenous chemotherapy with synchronization in advanced cancer of oral cavity and oropharynx
13. Chemotherapy - A new approach to the treatment of verrucous carcinoma
14. Mechanism of inhibition of cell proliferation by Vinca alkaloids
15. Interphase action of vinblastine and vincristine: Differences in their lethal action through the mitotic cycle of cultured mammalian cells
16. Vinca alkaloids, anti-vascular effects in a murine tumour
17. Anti-vascular approaches to solid tumour therapy: Evaluation of vinblastine and flovone acetic acid
18. Effect of vinblastine on celt membrane fluidity in vinblastine-sensitive and -resistant HeLa cells
19. Antitumor effectiveness of bleomycin on SA-1 tumor after pretreatment with vinblastine
20. The use of EPR for the measurement of the concentration of oxygen in vivo in tissues under physiologically pertinent conditions and concentrations
21. Potential for EPR oximetry to guide treatment planning for tumors
22. The measurement of oxygen in vivo using EPR techniques
23. 2 from tissue by in vivo EPR
24. Contrast-enhanced NMR imaging: Animal studies using gadolinium-DTPA complex
25. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers
26. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging
27. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution
28. Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses
29. Tumor blood flow modifying effect of electrochemotherapy with bleomycin
30. MRI macromolecular contrast agents as indicators of tumor stavation
31. Electron paramagnetic resonance and dynamic nuclear polarization of char suspensions: Surface science and oximetry
32. Improved skin oxygenation after benzyl nicotinate application in different carriers as measured by EPR oximetry
33. Antivascular approaches to solid tumour therapy: Evaluation of tumor binding agents
34. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
35. Surgical management of prostate cancer: Contemporary results with anatomic radical prostatectomy
36. Effects of novel and conventional anti-cancer agents on human endothelial permeability: Influence of tumour secreted factors
37. 2 measured by EPR oximetry in a murine mammary adenocarcinoma
38. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanism
39. Vascular toxicity associated with antineoplastic agents
40. Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy
41. Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin
42. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer